Skip to Main Content

INFORMATION FOR

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

To demonstrate the proof of principle and initial clinical safety of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve) and increase the efficiency of the device development process by identifying appropriate modifications to the implant procedure or the device.

  • Trial with
    CorMatrix Cardiovascular, Inc.
  • Start Date
    02/04/2021
  • End Date
    12/31/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000028726